CEP250 Antibody

What is CEP250 and what is its cellular localization pattern?

CEP250, also known as C-Nap1, is a coiled-coil protein that localizes to the proximal ends of mother and daughter centrioles. With a molecular weight of approximately 281 kDa, it functions primarily in maintaining centriole-centriole cohesion during the interphase of the cell cycle . During immunofluorescence studies, CEP250 typically appears as discrete foci at centrosomes, often positioned between two γ-tubulin signals when properly visualized . The protein dissociates from centrosomes at the beginning of mitosis when parental centrioles separate . When conducting localization studies, researchers should use high-resolution microscopy techniques, such as structured illumination or confocal microscopy with deconvolution, to properly resolve the precise positioning of CEP250 relative to other centrosomal components.

What are the recommended applications for CEP250 antibodies in research?

Based on extensive validation data, CEP250 antibodies are suitable for multiple applications, including:

For optimal results, each antibody should be titrated in your specific experimental system to determine the optimal working dilution . When selecting an antibody, prioritize those with documented reactivity to your species of interest, as human-reactive antibodies may not cross-react with rodent orthologs despite sequence similarity.

What fixation and permeabilization protocols are optimal for CEP250 immunostaining in different sample types?

For centrosomal protein detection including CEP250, fixation method selection is critical as it impacts epitope accessibility. Based on published protocols:

For cultured cells:

For tissue sections:

• For paraffin-embedded tissues, standard antigen retrieval methods using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) are recommended, with optimization for your specific antibody .

Permeabilization:

• For PFA-fixed samples, 0.2% Triton X-100 for 5 minutes has been successfully used in CEP250 immunodetection protocols .

• For dissociated testicular cells specifically (when studying CEP250 in spermatogenesis), the following protocol has proven effective: after fixation with 4% PFA, permeabilize with 0.2% Triton X-100 for 5 minutes .

How can I design co-localization experiments to study CEP250 interactions with other centrosomal proteins?

To effectively study CEP250's interactions with other centrosomal proteins:

• Antibody selection considerations:

  • Choose antibodies raised in different host species to avoid cross-reactivity (e.g., mouse anti-CEP250 and rabbit anti-γ-tubulin)

  • Validate each antibody individually before co-staining experiments

  • Use monoclonal antibodies when possible to reduce background

• Recommended co-staining partners:

  • γ-tubulin: Serves as general centrosome marker

  • Pericentrin: For PCM (pericentriolar material) localization

  • Centrin: For centriole identification

  • Nek2: To study kinase interactions with CEP250

• Imaging parameters for optimal co-localization analysis:

  • Use confocal microscopy with appropriate channel separation

  • Image at Nyquist sampling rate to enable deconvolution if needed

  • For quantitative co-localization, analyze using Pearson's or Mander's coefficients

  • Consider super-resolution techniques (STED, SIM, STORM) for detailed spatial relationships

• Control experiments must include:

  • Single antibody stains to confirm signal specificity

  • Secondary antibody-only controls to assess background

  • Peptide competition assays to validate antibody specificity

What are the expected banding patterns for CEP250 in Western blot analysis, and how do I troubleshoot unexpected results?

Expected patterns:

• Primary band at ~280 kDa representing full-length protein

• Potential lower molecular weight bands may represent isoforms or degradation products

Troubleshooting guidelines for common issues:

For optimal CEP250 detection, consider these specialized protocols:

• Use 6% SDS-PAGE gels to properly resolve high molecular weight proteins

• Transfer proteins at low voltage (30V) overnight at 4°C

• Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Primary antibody incubation in TBST for extended periods (overnight at 4°C)

How do I validate the specificity of a new CEP250 antibody before using it in my research?

Comprehensive validation of CEP250 antibodies should include multiple complementary approaches:

• Genetic validation:

  • Test antibody reactivity in CEP250 knockout or knockdown models

  • For example, using TALEN or CRISPR-generated CEP250-null cell lines

  • Analyze known CEP250-null mouse strains (e.g., the mouse strain with exon 5 targeted by TALEN)

• Peptide competition assays:

  • Pre-incubate antibody with immunizing peptide before application

  • Gradual signal reduction confirms specificity

• Multi-technique validation:

  • Western blot: Confirm band at expected molecular weight (~280 kDa)

  • Immunofluorescence: Verify centrosomal localization with co-staining

  • IP-MS: Confirm pull-down of known CEP250 interacting partners

• Cross-species reactivity assessment:

  • Test on samples from multiple species if cross-reactivity is desired

  • Alignment of epitope sequences across species can predict reactivity

• Knockout validation experiment protocol:

  • Perform side-by-side Western blot and immunofluorescence using wild-type and CEP250-null samples

  • Include positive controls (other centrosomal proteins like γ-tubulin)

  • Document complete loss of specific signal in knockout samples

What methodological approaches can be used to study CEP250's role in centriole cohesion during the cell cycle?

To investigate CEP250's dynamic role in centriole cohesion throughout the cell cycle:

• Live-cell imaging approaches:

  • Generate stable cell lines expressing CEP250-GFP fusion proteins

  • Use photobleaching techniques (FRAP/FLIP) to measure protein dynamics

  • Combine with cell cycle markers (e.g., PCNA-RFP) for phase identification

• Cell synchronization protocols for cell cycle analysis:

  • Double thymidine block for G1/S boundary

  • Nocodazole treatment for M-phase arrest

  • RO-3306 for G2/M boundary

  • Analyze CEP250 localization at each phase using immunofluorescence

• Protein-protein interaction analysis:

  • Proximity ligation assay (PLA) to detect interactions with Nek2 kinase

  • Co-immunoprecipitation followed by Western blot

  • FRET analysis for direct interaction measurement in live cells

• Functional perturbation experiments:

  • siRNA/shRNA-mediated depletion of CEP250

  • Expression of phosphomimetic or phospho-deficient CEP250 mutants

  • Analysis of centriole splitting phenotypes using centrin/γ-tubulin staining

• Quantitative analysis of centrosome cohesion:

  • Measure intercentriolar distance in control vs. CEP250-depleted cells

  • Analyze percentage of cells with split centrosomes across cell cycle phases

  • Correlate with cell division abnormalities

How can I experimentally investigate the connection between CEP250 mutations and Usher syndrome?

To study the relationship between CEP250 mutations and Usher syndrome, a methodical approach involving multiple experimental systems is recommended:

• Patient-derived cellular models:

  • Establish fibroblast cultures from patients with CEP250 mutations

  • Generate iPSCs and differentiate into relevant cell types (retinal and cochlear)

  • Analyze centrosome structure and function in these cell types

• CRISPR/Cas9 gene editing strategies:

  • Introduce specific patient mutations into model cell lines

  • Create isogenic control and mutant lines for direct comparison

  • Develop knock-in mouse models carrying patient-specific mutations

• Functional assays:

  • Centrosome organization: Immunofluorescence analysis of centriole cohesion

  • Cell division dynamics: Live imaging of mitotic progression

  • Ciliary function: Analysis of primary cilia formation and signaling

• Protein interaction studies:

  • Determine if mutations affect known CEP250 interactions (use Y2H or IP-MS)

  • Identify potentially disrupted interactions with retinal/cochlear proteins

  • Compare wild-type vs. mutant protein interactomes

• Phenotypic rescue experiments:

  • Express wild-type CEP250 in patient-derived cells

  • Assess normalization of centrosomal abnormalities

  • Evaluate restoration of ciliary function

• Tissue-specific analyses in animal models:

  • Focus on retinal and cochlear development and maintenance

  • Perform electrophysiological studies of sensory function

  • Correlate cellular phenotypes with sensory deficits

What experimental approaches should I use to study CEP250's function in spermatogenesis?

Based on recent discoveries of CEP250's critical role in male fertility and spermatogenesis, the following methodological approaches are recommended:

• Mouse model analysis protocols:

  • Generate or obtain CEP250-null mice (e.g., using TALEN technology targeting exon 5)

  • Perform fertility assessments (mating tests, sperm count, motility analysis)

  • Conduct histological analysis of testes at various developmental stages (5-21 weeks)

• Cellular markers for specific spermatogenic stages:

  • Undifferentiated spermatogonia: ZBTB16 (PLZF) immunostaining

  • Differentiating spermatogonia: c-KIT immunostaining

  • Meiotic entry: STRA8 immunostaining

  • DNA damage assessment: γH2AX immunostaining

  • Centrosome structure: γ-tubulin, pericentrin co-staining

• Detailed immunofluorescence protocols:

  • For testis sections: 4% PFA fixation, paraffin embedding, antigen retrieval

  • For chromosome spreads: preparation from seminiferous tubules, followed by blocking with gelatin solution (0.2% BSA, 0.2% gelatin, 0.05% Tween in PBS)

  • Primary antibody incubation: overnight at room temperature

  • Secondary antibody incubation: 1.5 hours at 37°C

• Quantitative analysis methods:

  • Count different germ cell populations in seminiferous tubule cross-sections

  • Measure meiotic progression by staging prophase I spermatocytes

  • Classify and quantify centrosomal defects using markers for inner core (CEP250) and outer core (centrin)

  • Document the three classes of centrosomal defects: detachment of inner core from outer core, splitting of outer core, and additional phenotypes

• RT-qPCR analysis:

  • Assess CEP250 expression in developmental time course

  • Compare expression levels between wild-type and heterozygous animals

  • Use appropriate reference genes for normalization in testicular tissue

How can I investigate the involvement of CEP250 in centrosomal protein complexes related to neurodevelopment?

To study CEP250's potential role in neurodevelopmental processes through its centrosomal interactions:

• Protein complex isolation and characterization:

  • Use tandem affinity purification (TAP) of CEP250 to identify interacting partners

  • Perform reciprocal co-immunoprecipitation to confirm interactions

  • Validate with proximity ligation assays in neural progenitor cells

• Mass spectrometry analysis workflow:

  • Immunoprecipitate CEP250 from neural progenitor cells or developing brain tissue

  • Process samples for LC-MS/MS analysis

  • Compare interactome with known microcephaly-associated centrosomal proteins (e.g., CDK5RAP2, CEP152, WDR62, CEP63)

• Functional assays in neural models:

  • Generate CEP250 knockdown/knockout in neural progenitor cells

  • Analyze proliferation defects (BrdU incorporation, Ki67 staining)

  • Assess centrosome abnormalities during asymmetric/symmetric divisions

  • Measure effects on neuronal migration using in utero electroporation

• Developmental timing analysis:

  • Compare CEP250 expression across brain developmental stages

  • Correlate with expression of other centrosomal microcephaly proteins

  • Analyze CEP250 distribution in different neural cell types

• Super-resolution microscopy approach:

  • Use 3D-SIM or STORM to map precise spatial organization of CEP250 relative to other centrosomal proteins

  • Quantify co-localization coefficients with CDK5RAP2, CEP152, and other centrosomal proteins

  • Compare organization in proliferating vs. differentiating neural cells

What are the best methods to study CEP250 autoantibodies in autoimmune conditions?

For researchers investigating CEP250 as an autoantigen in human autoimmune sera:

• Detection methods for anti-CEP250 autoantibodies:

  • Indirect immunofluorescence on HEp-2 cells (centrosomal pattern)

  • ELISA using recombinant CEP250 protein

  • Western blotting against recombinant CEP250

  • Multiplex bead assays incorporating CEP250 with other centrosomal autoantigens

• Protocol for screening autoimmune sera:

  • Initial screening by indirect immunofluorescence for centrosomal patterns

  • Confirmation with specific CEP250 immunoblotting

  • Test for co-reactivity with other centrosomal autoantigens (pericentrin, PCM-1, ninein)

  • Correlation with clinical features via retrospective chart review

• Characterization of autoantibody epitopes:

  • Generate a series of CEP250 deletion constructs

  • Express constructs in bacteria or mammalian cells

  • Screen patient sera against these fragments

  • Map immunodominant epitopes recognized by autoantibodies

• Clinical-immunological correlation approaches:

  • Establish cohorts of patients with centrosomal reactivity

  • Analyze specific anti-CEP250 reactivity patterns

  • Correlate with disease manifestations, severity, and progression

  • Compare with reactivity to other centrosomal proteins (PCM-1, pericentrin, ninein)

How can I optimize experimental protocols for studying CEP250 in parasites like Toxoplasma gondii?

When investigating CEP250 orthologs in parasites such as Toxoplasma gondii:

• Gene manipulation approaches:

  • Generate conditional knockdown systems using tetracycline-regulatable promoters

  • Create epitope-tagged versions (e.g., TgCep250-cKD parasite line)

  • Assess phenotypes using plaque assays to quantify parasite survival

• Phenotypic analysis protocol:

  • Immunofluorescence assay (IFA) to analyze nuclear and centrosomal defects

  • Use markers for:

    • Nucleus (DAPI staining)

    • Centrosome (TgCep250L1 for inner core, Centrin for outer core)

    • Cortical cytoskeleton (IMC3)

  • Classify centrosomal defects into distinct categories (e.g., detachment of inner core from outer core)

• Co-localization studies:

  • Use dual immunofluorescence with:

    • Anti-TgCep250 antibodies

    • Anti-centrin (outer core marker)

    • Anti-γ-tubulin (general centrosome marker)

  • Analyze using high-resolution microscopy with deconvolution

• Protein dynamics assessment:

  • Create fluorescently tagged TgCep250 constructs

  • Track protein localization throughout the parasite cell cycle

  • Use photobleaching techniques to measure protein turnover

• Quantitative analysis of nuclear partitioning defects:

  • Document percentage of vacuoles with mislocalized nuclei

  • Measure nuclear positioning relative to daughter cells

  • Classify defect patterns (e.g., anuclear parasites, nucleus retention in mother cell)